Familial hypercholesterolaemia
KEYWORDS: people, diagnosis, quality, statement, data, treatment, testing, clinical, children, specialist, hypercholesterolaemia, familial hypercholesterolaemia, clinical diagnosis, familial, source

of at-risk relatives can be monitored. Quality measures The following measures can be used to assess the quality of care or service provision specified in the statement. They are examples of how the statement can be measured, and can be adapted and used flexibly. Structure Evidence of local arrangements to ensure that people with FH are offered a structured review at least annually. Data source: Local data collection. Process Proportion of people with FH who receive a structured review at least annually. Numerator – The number of people in the denominator who had a structured review within 12 months of the last review or diagnosis. Denominator – The number of people with FH. Data source: Local data collection using a dedicated database. What the quality statement means for different audiences Serviceproviders ensure that systems are in place for people with FH to be offered a structured review at least annually. Healthcarepractitioners offer people with FH a structured review at least annually. Commissioners ensure that they commission services that offer a structured review at least annually to people with FH. People with FH are offered a detailed review of their condition at least once a year. Source guidance Familial hypercholesterolaemia: identification
